Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Oct 1;22(10):1560-6.
doi: 10.1161/01.atv.0000034707.40046.02.

HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells

Affiliations

HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells

Dian-sheng Zhong et al. Arterioscler Thromb Vasc Biol. .

Abstract

Objective: Although HIV protease inhibitors have been successfully used against HIV infection, many metabolic side effects and premature cardiovascular diseases are often associated with this therapy. The mechanisms of these complications are not clear. In this study, we investigated the effect of the HIV protease inhibitor ritonavir on human endothelial cell cultures.

Methods and results: By using nonradioactive cell proliferation and cytotoxicity assays, human endothelial cells treated with ritonavir showed a significant decrease in cell viability and an increase in cytotoxicity in a time- and dose-dependent fashion. Mitochondrial DNA was also substantially damaged with ritonavir treatment by long polymerase chain reaction analysis. In contrast, ritonavir had a very limited effect on endothelial apoptosis, as assessed by analyses of DNA fragmentation and cellular caspase-3 activity.

Conclusions: These data demonstrate, for the first time, that the HIV protease inhibitor ritonavir at concentrations near clinical plasma levels is able to directly cause endothelial mitochondrial DNA damage and cell death mainly through necrosis pathways but not through apoptosis. This study suggests that HIV protease inhibitor-mediated endothelial injury may contribute to its cardiovascular complications.

PubMed Disclaimer

Comment in

  • HIV therapies and atherosclerosis: answers or questions?
    Madamanchi NR, Patterson C, Runge MS. Madamanchi NR, et al. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1758-60. doi: 10.1161/01.atv.0000042080.46554.e6. Arterioscler Thromb Vasc Biol. 2002. PMID: 12426201 Review. No abstract available.

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources